Review
Early View Article
DOI DOI: 10.62063/rev-47

Targeting epigenetic checkpoints in autoimmune diseases: Nutritional and lifestyle interventions

Zaher Sabbagh1, Elif Sibel Aslan 1
  1. 1 Biruni University

Abstract

Autoimmune diseases are complex disorders arising from interactions among genetic susceptibility, epigenetic regulation, and environmental exposures. Accumulating evidence indicates that DNA methylation, histone modifications, and non-coding RNAs (ncRNAs) may mediate some of the effects of environmental factors on immune function and inflammatory responses. This narrative review examines how nutritional and lifestyle-related factors may influence epigenetic pathways relevant to autoimmune diseases. Evidence from in vitro studies, preclinical models, observational research, and emerging clinical investigations is synthesized, with particular emphasis on methyl-donor nutrients, selected bioactive compounds such as curcumin, vitamin D, physical activity, sleep and circadian regulation, and chronic psychological stress. Current findings suggest that these factors may modulate immune-related epigenetic processes; however, their clinical relevance remains constrained by differences in bioavailability, tissue specificity, individual biological variability, study design, and long-term adherence. Further longitudinal and intervention studies are therefore required to establish causality and clinical effectiveness. Overall, integrating nutritional and lifestyle factors with epigenetic and clinical profiling may support the future development of personalized adjunctive strategies for autoimmune disease management.

How to Cite

Sabbagh, Z., & Aslan , E. S. (2026). Targeting epigenetic checkpoints in autoimmune diseases: Nutritional and lifestyle interventions. EUCHEMBIOJ Reviews, 3(1), e27002. https://doi.org/10.62063/rev-47
Endnote/Zotero/Mendeley (RIS) BibTeX

References

  1. Alegría-Torres, J. A., Baccarelli, A., & Bollati, V. (2011). Epigenetics and lifestyle. Epigenomics, 3(3), 267–277. https://doi.org/10.2217/epi.11.22
  2. Armas Díaz, Y., Ferreiro Cotorruelo, M. S., & Battino, M. (2023). The role of dietary polyphenols in the control of chronic noncommunicable diseases. Food Safety and Health, 1(1). https://doi.org/10.1002/fsh3.12013
  3. Arvind, A., Sreelekshmi, S., & Dubey, N. (2025). Genetic, epigenetic, and hormonal regulation of stress phenotypes in major depressive disorder: From maladaptation to resilience. Cellular and Molecular Neurobiology, 45(1), 29. https://doi.org/10.1007/s10571-025-01549-x
  4. Augustine, T., Al-Aghbar, M. A., Al-Kowari, M., Espino-Guarch, M., & Van Panhuys, N. (2022). Asthma and the missing heritability problem: Necessity for multiomics approaches in determining accurate risk profiles. Frontiers in Immunology, 13, 822324. https://doi.org/10.3389/fimmu.2022.822324
  5. Awuah, W. A., Huang, H., Kalmanovich, J., Mehta, A., Mikhailova, T., Ng, J. C., Abdul-Rahman, T., Adebusoye, F. T., Tan, J. K., Kamanousa, K., Ferreira, T., Roy, S., Kundu, M., Yarlagadda, R., Mukerjee, N., Alexiou, A., & Papadakis, M. (2023). Circadian rhythm in systemic autoimmune conditions: Potential of chrono-immunology in clinical practice: A narrative review. Medicine, 102(32), e34614. https://doi.org/10.1097/MD.0000000000034614
  6. Bagni, G., Biancalana, E., Chiara, E., Costanzo, I., Malandrino, D., Lastraioli, E., Palmerini, M., Silvestri, E., Urban, M. L., & Emmi, G. (2025). Epigenetics in autoimmune diseases: Unraveling the hidden regulators of immune dysregulation. Autoimmunity Reviews, 24(6), 103784. https://doi.org/10.1016/j.autrev.2025.103784
  7. Balakin, E., Yurku, K., Ivanov, M., Izotov, A., Nakhod, V., & Pustovoyt, V. (2025). Regulation of stress-induced immunosuppression in the context of neuroendocrine, cytokine, and cellular processes. Biology, 14(1), 76. https://doi.org/10.3390/biology14010076
  8. Banker, M., Jansen, E. C., Goodrich, J. M., English, L., Dolinoy, D. C., Song, P. X. K., Mitchell, J. A., Téllez-Rojo, M. M., Cantoral, A., & Peterson, K. E. (2024). Associations between sleep and physical activity behavior clusters and epigenetic age acceleration in Mexican adolescents. Medicine and Science in Sports and Exercise, 56(11), 2173–2183. https://doi.org/10.1249/MSS.0000000000003498
  9. Bannister, A. J., & Kouzarides, T. (2011). Regulation of chromatin by histone modifications. Cell Research, 21(3), 381–395. https://doi.org/10.1038/cr.2011.22
  10. Barrès, R., Yan, J., Egan, B., Treebak, J. T., Rasmussen, M., Fritz, T., Caidahl, K., Krook, A., O’Gorman, D. J., & Zierath, J. R. (2012). Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metabolism, 15(3), 405–411. https://doi.org/10.1016/j.cmet.2012.01.001
  11. Bechara, R., Vagner, S., & Mariette, X. (2023). Post-transcriptional checkpoints in autoimmunity. Nature Reviews Rheumatology, 19(8), 486–502. https://doi.org/10.1038/s41584-023-00980-y
  12. Bernasocchi, T., & Mostoslavsky, R. (2024). Subcellular one carbon metabolism in cancer, aging and epigenetics. Frontiers in Epigenetics and Epigenomics, 2. https://doi.org/10.3389/freae.2024.1451971
  13. Borel, P., Caillaud, D., & Cano, N. J. (2013). Vitamin D bioavailability: state of the art. Critical Reviews in Food Science and Nutrition, 55(9), 1193–1205. https://doi.org/10.1080/10408398.2012.688897
  14. Boyanapalli, S. S. S., & Kong, A. N. T. (2015). “Curcumin, the King of Spices”: Epigenetic regulatory mechanisms in the prevention of cancer, neurological, and inflammatory diseases. Current Pharmacology Reports, 1(2), 129–139. https://doi.org/10.1007/s40495-015-0018-x
  15. Carlberg, C., & Velleuer, E. (2024). Vitamin D and aging: Central role of immunocompetence. Nutrients, 16(3), 398. https://doi.org/10.3390/nu16030398
  16. Cedernaes, J., Schönke, M., Westholm, J. O., Mi, J., Chibalin, A., Voisin, S., Osler, M., Vogel, H., Hörnaeus, K., Dickson, S. L., Lind, S. B., Bergquist, J., Schiöth, H. B., Zierath, J. R., & Benedict, C. (2018). Acute sleep loss results in tissue-specific alterations in genome-wide DNA methylation state and metabolic fuel utilization in humans. Science Advances, 4(8), eaar8590. https://doi.org/10.1126/sciadv.aar8590
  17. Chaudhary, R., Prasad, A., Agarwal, V., Rehman, M., Kumar, A., Kaushik, A. S., Srivastava, S., Srivastava, S., & Mishra, V. (2023). Chronic stress predisposes to the aggravation of inflammation in autoimmune diseases with focus on rheumatoid arthritis and psoriasis. International Immunopharmacology, 125(Part A), 111046. https://doi.org/10.1016/j.intimp.2023.111046
  18. Chauss, D., Freiwald, T., McGregor, R., Yan, B., Wang, L., Nova-Lamperti, E., Kumar, D., Zhang, Z., Teague, H., West, E. E., Vannella, K. M., Ramos-Benitez, M. J., Bibby, J., Kelly, A., Malik, A., Freeman, A. F., Schwartz, D. M., Portilla, D., Chertow, D. S., … Afzali, B. (2021). Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells. Nature Immunology, 23(1), 62–74. https://doi.org/10.1038/s41590-021-01080-3
  19. Cho, J. H., & Gregersen, P. K. (2011). Genomics and the multifactorial nature of human autoimmune disease. New England Journal of Medicine, 365(17), 1612–1623. https://doi.org/10.1056/nejmra1100030
  20. Choi, S., & Friso, S. (2023). Modulation of DNA methylation by one-carbon metabolism: a milestone for healthy aging. Nutrition Research and Practice, 17(4), 597. https://doi.org/10.4162/nrp.2023.17.4.597
  21. Ciechomska, M., & O’Reilly, S. (2016). Epigenetic modulation as a therapeutic prospect for treatment of autoimmune rheumatic diseases. Mediators of Inflammation, 2016, 1–11. https://doi.org/10.1155/2016/9607946
  22. Conrad, N., Misra, S., Verbakel, J. Y., Verbeke, G., Molenberghs, G., Taylor, P. N., Mason, J., Sattar, N., McMurray, J. J. V., McInnes, I. B., Khunti, K., & Rahimi, K. (2023). Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: A population-based cohort study of 22 million individuals in the UK. The Lancet, 401(10391), 1878–1890. https://doi.org/10.1016/S0140-6736(23)00457-9
  23. Costenbader, K. H., Gay, S., Alarcón-Riquelme, M. E., Iaccarino, L., & Doria, A. (2011). Genes, epigenetic regulation and environmental factors: Which is the most relevant in developing autoimmune diseases? Autoimmunity Reviews, 11(8), 604–609. https://doi.org/10.1016/j.autrev.2011.10.022
  24. Di Liberto, D., Scazzone, C., La Rocca, G., Cipriani, P., Lo Pizzo, M., Ruscitti, P., Agnello, L., Ciaccio, M., Dieli, F., Giacomelli, R., Triolo, G., Ciccia, F., Sireci, G., & Guggino, G. (2019). Vitamin D increases the production of IL-10 by regulatory T cells in patients with systemic sclerosis. Clinical and Experimental Rheumatology, 37 Suppl 119(4), 76–81. https://pubmed.ncbi.nlm.nih.gov/31587692/
  25. Dhanapal, A. C. T. A., & Vimaleswaran, K. S. (2022). Vitamin D supplementation and immune-related markers: An update from nutrigenetic and nutrigenomic studies. British Journal of Nutrition, 128(8), 1459–1469. https://doi.org/10.1017/S0007114522002392
  26. Ducker, G. S., & Rabinowitz, J. D. (2016). One-carbon metabolism in health and disease. Cell Metabolism, 25(1), 27–42. https://doi.org/10.1016/j.cmet.2016.08.009
  27. Ekmekci̇, H. S., & Muftarevi̇Ç, S. (2023). Epigenetic effects of social stress and epigenetic inheritance. Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry, 15(1), 132–145. https://doi.org/10.18863/pgy.1059315
  28. Esteller, M. (2011). Non-coding RNAs in human disease. Nature Reviews Genetics, 12(12), 861–874. https://doi.org/10.1038/nrg3074
  29. Fagiani, F., Di Marino, D., Romagnoli, A., Travelli, C., Voltan, D., Di Cesare Mannelli, L., Racchi, M., Govoni, S., & Lanni, C. (2022). Molecular regulations of circadian rhythm and implications for physiology and diseases. Signal Transduction and Targeted Therapy, 7(1), 41. https://doi.org/10.1038/s41392-022-00899-y
  30. Farh, K. K., Marson, A., Zhu, J., Kleinewietfeld, M., Housley, W. J., Beik, S., Shoresh, N., Whitton, H., Ryan, R. J. H., Shishkin, A. A., Hatan, M., Carrasco-Alfonso, M. J., Mayer, D., Luckey, C. J., Patsopoulos, N. A., De Jager, P. L., Kuchroo, V. K., Epstein, C. B., Daly, M. J., … Bernstein, B. E. (2014). Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature, 518(7539), 337–343. https://doi.org/10.1038/nature13835
  31. Fernandez, G. J., Ramírez-Mejía, J. M., & Urcuqui-Inchima, S. (2022). Vitamin D boosts immune response of macrophages through a regulatory network of microRNAs and mRNAs. The Journal of Nutritional Biochemistry, 109, 109105. https://doi.org/10.1016/j.jnutbio.2022.109105
  32. Ferrer, J., & Dimitrova, N. (2024). Transcription regulation by long non-coding RNAs: Mechanisms and disease relevance. Nature Reviews Molecular Cell Biology, 25(5), 396–415. https://doi.org/10.1038/s41580-023-00694-9
  33. Ferioli, M., Zauli, G., Maiorano, P., Milani, D., Mirandola, P., & Neri, L. M. (2019). Role of physical exercise in the regulation of epigenetic mechanisms in inflammation, cancer, neurodegenerative diseases, and aging process. Journal of Cellular Physiology, 234(9), 14852–14864. https://doi.org/10.1002/jcp.28304
  34. Fetahu, I. S., Höbaus, J., & Kállay, E. (2014). Vitamin D and the epigenome. Frontiers in Physiology, 5, 164. https://doi.org/10.3389/fphys.2014.00164
  35. Ghisays, F., Brace, C. S., Yackly, S. M., Kwon, H. J., Mills, K. F., Kashentseva, E., Dmitriev, I. P., Curiel, D. T., Imai, S., & Ellenberger, T. (2015). The The N-terminal domain of SIRT1 is a positive regulator of endogenous SIRT1-dependent deacetylation and transcriptional outputs. Cell Reports, 10(10), 1665–1673. https://doi.org/10.1016/j.celrep.2015.02.036
  36. Guha, S., Jagadeesan, Y., Pandey, M. M., Mittal, A., & Chitkara, D. (2024). Targeting the epigenome with advanced delivery strategies for epigenetic modulators. Bioengineering & Translational Medicine, 10(1), e10710. https://doi.org/10.1002/btm2.10710
  37. Guo, W., Meydani, S. N., & Wu, D. (2026). Bioactive phytochemicals in experimental models of multiple sclerosis: Mechanisms, efficacy, and translational potential. Nutrients, 18(2), 278. https://doi.org/10.3390/nu18020278
  38. Hardy, R. S., Raza, K., & Cooper, M. S. (2012). Endogenous glucocorticoids in inflammation: contributions of systemic and local responses. Swiss Medical Weekly, 142(3132), w13650. https://doi.org/10.4414/smw.2012.13650
  39. Hombach, S., & Kretz, M. (2016). Non-coding RNAs: Classification, biology and functioning. Advances in Experimental Medicine and Biology, 937, 3–17. https://doi.org/10.1007/978-3-319-42059-2_1
  40. Hussain, S. A., Sarker, M. I., Liu, Y., & Jin, T. Z. (2026). DNA methylation and its role in personalized nutrition: mechanisms, clinical insights, and future perspectives. International Journal of Molecular Sciences, 27(2), 566. https://doi.org/10.3390/ijms27020566
  41. Irwin, M. R., Wang, M., Ribeiro, D., Cho, H. J., Olmstead, R., Breen, E. C., Martinez-Maza, O., & Cole, S. (2008). Sleep loss activates cellular inflammatory signaling. Biological Psychiatry, 64(6), 538–540. https://doi.org/10.1016/j.biopsych.2008.05.004
  42. Irwin, M. R. (2022). Sleep disruption induces activation of inflammation and heightens risk for infectious disease: Role of impairments in thermoregulation and elevated ambient temperature. Temperature, 10(2), 198–234. https://doi.org/10.1080/23328940.2022.2109932
  43. Issa, J. (2014). Aging and epigenetic drift: a vicious cycle. Journal of Clinical Investigation, 124(1), 24–29. https://doi.org/10.1172/jci69735
  44. Jafleh, E. A., Alnaqbi, F. A., Almaeeni, H. A., Faqeeh, S., Alzaabi, M. A., & Zaman, K. A. (2024). The role of wearable devices in chronic disease monitoring and patient care: A comprehensive review. Cureus, 16(9), e68921. https://doi.org/10.7759/cureus.68921
  45. Jalouli, M., Rahman, M. A., Biswas, P., Rahman, H., Harrath, A. H., Lee, I., Kang, S., Choi, J., Park, M. N., & Kim, B. (2025). Targeting natural antioxidant polyphenols to protect neuroinflammation and neurodegenerative diseases: a comprehensive review. Frontiers in Pharmacology, 16, 1492517. https://doi.org/10.3389/fphar.2025.1492517
  46. Jiao, H., Wang, X., Zhang, D., Zhou, S., & Gao, F. (2025). Curcumin and neuroplasticity: epigenetic mechanisms underlying cognitive enhancement in aging and neurodegenerative disorders. Frontiers in Aging Neuroscience, 17, 1592280. https://doi.org/10.3389/fnagi.2025.1592280
  47. Jimeno, B., Hau, M., Gómez-Díaz, E., & Verhulst, S. (2019). Developmental conditions modulate DNA methylation at the glucocorticoid receptor gene with cascading effects on expression and corticosterone levels in zebra finches. Scientific Reports, 9(1). https://doi.org/10.1038/s41598-019-52203-8
  48. Jonkers, I. H., & Wijmenga, C. (2017). Context-specific effects of genetic variants associated with autoimmune disease. Human Molecular Genetics, 26(R2), R185–R192. https://doi.org/10.1093/hmg/ddx254
  49. Kamal, K. M., Ghazali, A. R., Mutalib, N. S. A., Abu, N., Chua, E. W., & Masre, S. F. (2024). The role of DNA methylation and DNA methyltransferases (DNMTs) as potential biomarker and therapeutic target in non-small cell lung cancer (NSCLC). Heliyon, 10(19), e38663. https://doi.org/10.1016/j.heliyon.2024.e38663
  50. Kaufman, J., DeLorenzo, C., Choudhury, S., & Parsey, R. V. (2016). The 5-HT1A receptor in Major Depressive Disorder. European Neuropsychopharmacology, 26(3), 397–410. https://doi.org/10.1016/j.euroneuro.2015.12.039
  51. Kciuk, M., Alam, M., Ali, N., Rashid, S., Głowacka, P., Sundaraj, R., Celik, I., Yahya, E. B., Dubey, A., Zerroug, E., & Kontek, R. (2023). Epigallocatechin-3-Gallate therapeutic potential in cancer: mechanism of action and clinical implications. Molecules, 28(13), 5246. https://doi.org/10.3390/molecules28135246
  52. Khedr, A. M. B., Shaker, O. G., Hassan, A., Hussein, M., Kamal, Y. S., & Azouz, T. A. (2022). MicroRNA-22 level in patients with multiple sclerosis and its relationship with vitamin D and vitamin D receptor levels. Neuroimmunomodulation, 29(2), 128–134. https://doi.org/10.1159/000519012
  53. Kim, J. Y., & Kim, J. W. (2026). Toxicoepigenomics: Epigenetic disruption by environmental exposures and implications for biomarker development. Journal of Hazardous Materials, 502, 141070. https://doi.org/10.1016/j.jhazmat.2026.141070
  54. Kino, T., Nicolaides, N. C., Charmandari, E., & Chrousos, G. P. (2024, May 19). Primary generalized glucocorticoid resistance syndrome. Endotext - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK278930/
  55. Korolenya, V. A., Filipenko, M. L., & Smetanina, M. A. (2025). Epigenome-wide search for distinctive methylation biomarkers of endothelial and leukocyte DNA. Epigenomes, 9(4), 53. https://doi.org/10.3390/epigenomes9040053
  56. Kotewitsch, M., Heimer, M., Schmitz, B., & Mooren, F. C. (2024). Non-coding RNAs in exercise immunology: A systematic review. Journal of Sport and Health Science, 13(3), 311–338. https://doi.org/10.1016/j.jshs.2023.11.001
  57. Kumar, D., Sahoo, S. S., Chauss, D., Dimitrion, P., Chatterjee, P., Rotzschke, O., Cook, H. T., & Afzali, B. (2023). Non-coding RNAs in immunoregulation and autoimmunity: Technological advances and critical limitations. Journal of Autoimmunity, 134, 102982. https://doi.org/10.1016/j.jaut.2022.102982
  58. Kumar, V., Kesharwani, R., Patel, D. K., Verma, A., Mehanna, M. G., Mohammad, A., Bawadood, A. S., Al-Abbasi, F. A., & Anwar, F. (2025). Epigenetic impact of curcumin and thymoquinone on cancer therapeutics. Current Medicinal Chemistry, 32(11). https://doi.org/10.2174/0109298673288542240327112351
  59. Laurindo, L. F., De Carvalho, G. M., De Oliveira Zanuso, B., Figueira, M. E., Direito, R., De Alvares Goulart, R., Buglio, D. S., & Barbalho, S. M. (2023). Curcumin-based nanomedicines in the treatment of inflammatory and immunomodulated diseases: An evidence-based comprehensive review. Pharmaceutics, 15(1), 229. https://doi.org/10.3390/pharmaceutics15010229
  60. Leone, P., Susca, N., & Racanelli, V. (2026). Editorial: Autoimmune diseases: from molecular mechanisms to therapy development. Frontiers in Immunology, 16, 1768955. https://doi.org/10.3389/fimmu.2025.1768955
  61. Liang, J., Jahraus, B., Balta, E., Ziegler, J. D., Hübner, K., Blank, N., Niesler, B., Wabnitz, G. H., & Samstag, Y. (2018). Sulforaphane inhibits inflammatory responses of primary human T-Cells by increasing ROS and depleting glutathione. Frontiers in Immunology, 9, 2584. https://doi.org/10.3389/fimmu.2018.02584
  62. Liu, S., Zahorchak, A. F., Dobrowolski, S. F., Metes, D. M., Thomson, A. W., & Abdelsamed, H. A. (2024). Epigenetic signature of human vitamin D3 and IL-10 conditioned regulatory DCs. Scientific Reports, 14(1), 28748. https://doi.org/10.1038/s41598-024-79299-x
  63. Luo, B., Xiang, D., Ji, X., Chen, X., Li, R., Zhang, S., Meng, Y., Nieman, D. C., & Chen, P. (2024). The anti-inflammatory effects of exercise on autoimmune diseases: A 20-year systematic review. Journal of Sport and Health Science, 13(3), 353–367. https://doi.org/10.1016/j.jshs.2024.02.002
  64. Machado, O. A. S., Diniz, V. L. S., Passos, M. E. P., de Oliveira, H. H., Santos-Oliveira, L. C., Alecrim, A. L., Bertola Lobato, T., Manoel, R., Correa, I., Silva, E. B., de Oliveira Poma, S., Mendes de Almeida, M., Pithon-Curi, T. C., Diniz, S., Levada-Pires, A. C., Curi, R., Masi, L. N., Hirabara, S. M., & Gorjão, R. (2021). Physical exercise increases global and gene-specific (Interleukin-17 and interferon-γ) DNA methylation in lymphocytes from aged women. Experimental Physiology, 106(9), 1878–1885. https://doi.org/10.1113/EP089673
  65. Mahmoud, A. M., & Ali, M. M. (2019). Methyl donor micronutrients that modify DNA methylation and cancer outcome. Nutrients, 11(3), 608. https://doi.org/10.3390/nu11030608
  66. Manna, I., De Benedittis, S., & Porro, D. (2024). A comprehensive examination of the role of epigenetic factors in multiple sclerosis. International Journal of Molecular Sciences, 25(16), 8921. https://doi.org/10.3390/ijms25168921
  67. Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., Cho, J. H., Guttmacher, A. E., Kong, A., Kruglyak, L., Mardis, E., Rotimi, C. N., Slatkin, M., Valle, D., Whittemore, A. S., … Visscher, P. M. (2009). Finding the missing heritability of complex diseases. Nature, 461(7265), 747–753. https://doi.org/10.1038/nature08494
  68. Marangoni, K., Dorneles, G., Da Silva, D. M., Pinto, L. P., Rossoni, C., & Fernandes, S. A. (2023). Diet as an epigenetic factor in inflammatory bowel disease. World Journal of Gastroenterology, 29(41), 5618–5629. https://doi.org/10.3748/wjg.v29.i41.5618
  69. Masri, S., & Sassone-Corsi, P. (2014). Sirtuins and the circadian clock: Bridging chromatin and metabolism. Science Signaling, 7(342), re6. https://doi.org/10.1126/scisignal.2005685
  70. Mazur, A., Frączek, P., & Tabarkiewicz, J. (2022). Vitamin D as a nutri-epigenetic factor in autoimmunity—A review of current research and reports on vitamin D deficiency in autoimmune diseases. Nutrients, 14(20), 4286. https://doi.org/10.3390/nu14204286
  71. Meda, F., Folci, M., Baccarelli, A., & Selmi, C. (2011). The epigenetics of autoimmunity. Cellular and Molecular Immunology, 8(3), 226–236. https://doi.org/10.1038/cmi.2010.78
  72. Mentch, S. J., & Locasale, J. W. (2016). One-carbon metabolism and epigenetics: Understanding the specificity. Annals of the New York Academy of Sciences, 1363(1), 91–98. https://doi.org/10.1111/nyas.12956
  73. Meral, G., Aslan, E. S., Burkay, N., Ozkaya, M., & Alper Acar, E. G. (2026). The effects of green tea and curcumin on COMT and MAO pathways in nutrigenetics-based epigenetic approaches: Clinical benefits and the balanced management of psycho-oncological risks. EUCHEMBIOJ Reviews, 2(1), Article e26005. https://doi.org/10.62063/rev-40
  74. Miller, M., McAfee, C., Brown, R. D., Sears, S., Krautkramer, C., Gogia, R., Wylie, D., Josephs, R. A., & Champagne, F. A. (2025). Impact of acute stress exposure on genome-wide DNA methylation. Scientific Reports, 15(1), 23931. https://doi.org/10.1038/s41598-025-09299-y
  75. Musazzi, L., Mingardi, J., Ieraci, A., Popoli, M., & Treccani, G. (2023). Stress, microRNAs, and stress-related psychiatric disorders: An overview. Molecular Psychiatry, 28, 4977–4994. https://doi.org/10.1038/s41380-023-02139-3
  76. Nemeth, K., Bayraktar, R., Ferracin, M., & Calin, G. A. (2024). Non-coding RNAs in disease: From mechanisms to therapeutics. Nature Reviews Genetics, 25(3), 211–232. https://doi.org/10.1038/s41576-023-00662-1
  77. Office of Autoimmune Disease Research (OADR-ORWH). (2025, April 24). https://orwh.od.nih.gov/OADR-ORWH
  78. Orozco-Solis, R., & Aguilar-Arnal, L. (2020). Circadian regulation of immunity through epigenetic mechanisms. Frontiers in Cellular and Infection Microbiology, 10, 96. https://doi.org/10.3389/fcimb.2020.00096
  79. Ostaiza-Cardenas, J., Tobar, A. C., Costa, S. C., Calero, D. S., López-Carrera, A., Bermúdez, F. G., & Orellana-Manzano, A. (2025). Epigenetic modulation by lifestyle: Advances in diet, exercise, and mindfulness for disease prevention and health optimization. Frontiers in Nutrition, 12, 1632999. https://doi.org/10.3389/fnut.2025.1632999
  80. Osum, M., & Kalkan, R. (2025). Circadian rhythm, epigenetics and disease interaction. Global Medical Genetics, 12(1), 100006. https://doi.org/10.1016/j.gmg.2024.100006
  81. Panni, S., Lovering, R. C., Porras, P., & Orchard, S. (2020). Non-coding RNA regulatory networks. Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms, 1863(6), 194417. https://doi.org/10.1016/j.bbagrm.2019.194417
  82. Pisetsky, D. S. (2023). Pathogenesis of autoimmune disease. Nature Reviews Nephrology, 19(8), 509–524. https://doi.org/10.1038/s41581-023-00720-1
  83. Pratama, B. P., Khairullah, A. R., Ma’ruf, I. F., Akintunde, A. O., Mustofa, I., Mulyati, S., Ahmad, R. Z., & Ansori, A. N. M. (2025). Revolutionizing curcumin bioavailability: From health benefits to placement in food packaging products. Food Systems, 8(3), 343–354. https://doi.org/10.21323/2618-9771-2025-8-3-343-354
  84. Qahtan, F., Abu-Qiyas, S., & Papandreou, D. (2026). Genetic and epigenetic determinants of vitamin D metabolism: nutrigenomic insights for precision nutrition. Frontiers in Nutrition, 13, 1772849. https://doi.org/10.3389/fnut.2026.1772849
  85. Ramos-Martínez, E., Falfán-Valencia, R., Pérez-Rubio, G., García-Vázquez, F. J., Rojas-Serrano, J., Heredia-Antúnez, A. P., Aristi-Urista, G., & Chavarria-Krauser, A. (2026). Treatment with curcumin delays the development of type 1 diabetes mellitus by decreasing proinflammatory cytokines in non-obese diabetic mice. Diabetology, 7(2), 31. https://doi.org/10.3390/diabetology7020031
  86. Sadee, W., Hartmann, K., Seweryn, M., Pietrzak, M., Handelman, S. K., & Rempala, G. A. (2014). Missing heritability of common diseases and treatments outside the protein-coding exome. Human Genetics, 133(10), 1199–1215. https://doi.org/10.1007/s00439-014-1476-7
  87. Saleh, R., Toor, S. M., Nair, V. S., & Elkord, E. (2020). Role of epigenetic modifications in inhibitory immune checkpoints in cancer development and progression. Frontiers in Immunology, 11, 1469. https://doi.org/10.3389/fimmu.2020.01469
  88. Sareen, S., Bakovic, M., & Cho, C. E. (2026). Choline and DNA methylation: impact across metabolic, oncogenic and neurodevelopmental disorders. Clinical Epigenetics, 18(1). https://doi.org/10.1186/s13148-026-02086-0
  89. Sun, T., Wu, Y., Kong, L., Wang, J., Zhang, F., Liu, Y., Gao, J., & Liu, Y. (2025). MTHFR polymorphisms in autoimmune diseases: Mechanistic and clinical perspectives. Autoimmunity Reviews, 25(1), 103939. https://doi.org/10.1016/j.autrev.2025.103939
  90. Surace, A. E. A., & Hedrich, C. M. (2019). The role of epigenetics in autoimmune/inflammatory disease. Frontiers in Immunology, 10, 1525. https://doi.org/10.3389/fimmu.2019.01525
  91. Sîrbe, C., Rednic, S., Grama, A., & Pop, T. L. (2022). An update on the effects of vitamin D on the immune system and autoimmune diseases. International Journal of Molecular Sciences, 23(17), 9784. https://doi.org/10.3390/ijms23179784
  92. Takahashi, J. S. (2017). Transcriptional architecture of the mammalian circadian clock. Nature Reviews. Genetics, 18(3), 164–179. https://doi.org/10.1038/nrg.2016.150
  93. Tortorella, S. M., Royce, S. G., Licciardi, P. V., & Karagiannis, T. C. (2014). Dietary sulforaphane in cancer chemoprevention: The role of epigenetic regulation and HDAC inhibition. Antioxidants and Redox Signaling, 22(16), 1382–1424. https://doi.org/10.1089/ars.2014.6097
  94. Tyrka, A. R., Price, L. H., Marsit, C., Walters, O. C., & Carpenter, L. L. (2012). Childhood adversity and epigenetic modulation of the leukocyte glucocorticoid receptor: preliminary findings in healthy adults. PLoS ONE, 7(1), e30148. https://doi.org/10.1371/journal.pone.0030148
  95. Tyrka, A. R., Parade, S. H., Eslinger, N. M., Marsit, C. J., Lesseur, C., Armstrong, D. A., Philip, N. S., Josefson, B., & Seifer, R. (2015). Methylation of exons 1d, 1f, and 1h of the glucocorticoid receptor gene promoter and exposure to adversity in pre-school aged children. Development and Psychopathology, 27(2), 577–585. https://doi.org/10.1017/S0954579415000176
  96. Usategui-Martín, R., De Luis-Román, D., Fernández-Gómez, J. M., Ruiz-Mambrilla, M., & Pérez-Castrillón, J. (2022). Vitamin D receptor (VDR) gene polymorphisms modify the response to vitamin D supplementation: A systematic review and meta-analysis. Nutrients, 14(2), 360. https://doi.org/10.3390/nu14020360
  97. von Hattburg, A. T. (2025). Epigenetics and life extension: The role of epigenetic modifications in ageing and reversing biological age through lifestyle interventions. American Journal of Biomedical Science & Research, 25(3). https://doi.org/10.34297/AJBSR.2025.25.003379
  98. Weeding, E., & Sawalha, A. H. (2018). Deoxyribonucleic acid methylation in systemic lupus erythematosus: implications for future clinical practice. Frontiers in Immunology, 9, 875. https://doi.org/10.3389/fimmu.2018.00875
  99. Wei, Z., Li, H., Lv, S., & Yang, J. (2024). Current situation and trend of non-coding RNA in rheumatoid arthritis: A review and bibliometric analysis. Frontiers in Immunology, 14, Article 1301545. https://doi.org/10.3389/fimmu.2023.1301545
  100. Xu, Y., Wang, Y., Jiang, Y., Liu, M., Zhong, W., Ge, Z., Sun, Z., & Shen, X. (2023). Relationship between cognitive dysfunction and the promoter methylation of PER1 and CRY1 in patients with cerebral small vessel disease. Frontiers in Aging Neuroscience, 15, 1174541. https://doi.org/10.3389/fnagi.2023.1174541
  101. Xu, Y., Yang, S., & Cao, C. (2025). Glucocorticoid receptor gene (NR3C1) methylation, childhood maltreatment, multilevel reward responsiveness and depressive and anxiety symptoms: A neuroimaging epigenetic study. NeuroImage, 306, 121003. https://doi.org/10.1016/j.neuroimage.2025.121003
  102. Yang, Q., Hu, Y., Zhang, B., & Hong, W. (2025). Exercise-induced epigenetic modifications: Implications for healthy aging. International Journal of Sports Medicine. https://doi.org/10.1055/a-2702-4789
  103. Yang, X., Zhang, Y., Wang, X., Chen, S., Zheng, Y., Hou, X., Wang, S., Zheng, X., Li, Q., Sun, Y., & Wu, J. (2024). Exercise-mediated epigenetic modifications in cardiovascular diseases. Epigenomics, 17(3), 179–191. https://doi.org/10.1080/17501911.2024.2447811
  104. Ye, X., Ho, Y., & Chang, R. C. (2025). Re-examination of inflammation in major depressive disorder: Bridging systemic and neuroinflammatory insights. Biomolecules, 15(11), 1556. https://doi.org/10.3390/biom15111556
  105. Yu, X., Zecharia, A., Zhang, Z., Yang, Q., Yustos, R., Jager, P., Vyssotski, A. L., Maywood, E. S., Chesham, J. E., Ma, Y., Brickley, S. G., Hastings, M. H., Franks, N. P., & Wisden, W. (2014). Circadian factor BMAL1 in histaminergic neurons regulates sleep architecture. Current Biology, 24(23), 2838–2844. https://doi.org/10.1016/j.cub.2014.10.019
  106. Zannas, A. S. (2019). Epigenetics as a key link between psychosocial stress and aging: Concepts, evidence, mechanisms. Dialogues in Clinical Neuroscience, 21(4), 389–396. https://doi.org/10.31887/DCNS.2019.21.4/azannas
  107. Zannas, A. (2021). Naturalistic Stress Hormone Levels Drive Cumulative Epigenomic Changes along the Cellular Lifespan. International Journal of Molecular Sciences, 22(16), 8778. https://doi.org/10.3390/ijms22168778
  108. Zeisberg, E. M., & Zeisberg, M. (2012). The role of promoter hypermethylation in fibroblast activation and fibrogenesis. The Journal of Pathology, 229(2), 264–273. https://doi.org/10.1002/path.4120
  109. Zhao, Z., Chen, Q., Qiao, X., Wang, J., Ali, Z. T. A., Li, J., & Yin, L. (2025). Sulforaphane in cancer precision medicine: from biosynthetic origins to multiscale mechanisms and clinical translation. Frontiers in Immunology, 16, 1702860. https://doi.org/10.3389/fimmu.2025.1702860
  110. Zheng, X., Liu, X., Guo, Y., Lv, Y., Lin, C., Wang, D., Wang, S., Liu, Y., & Hu, X. (2025). Physical exercise and epigenetic modifications in skeletal muscle, brain, and heart. Epigenetics & Chromatin, 18(1), 12. https://doi.org/10.1186/s13072-025-00576-8
  111. Zhou, A., & Ryan, J. (2023). Biological embedding of Early-Life adversity and a scoping review of the evidence for intergenerational epigenetic transmission of stress and trauma in humans. Genes, 14(8), 1639. https://doi.org/10.3390/genes14081639